Pancreatic Cancer Research

ResearcherMasaryk UniversityActive in the last 2 years

Petr Dítě DrSc

Matched on ORCID iD 0000-0002-1882-3051; OpenAlex author ID A5076724425. Sources: OpenAlex.

Their work

Papers
14 (first author 6, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2011: 2 papers · 2012: 2 papers · 2013: none · 2014: 2 papers · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 3 papers · 2022: none · 2023: none · 2024: 3 papers

Papers 14

  1. Gut microbio-me and pancreatic cancer. Last author DOI 10.48095/ccko202420↗
  2. Autoimmune pancreatitis as a risk factor of pancreatic cancer. First author DOI 10.48095/ccko2024420↗
  3. Acute pancreatitis as a risk factor of chronic pancreatitis and pancreatic cancer. An overview. First author DOI 10.5507/bp.2024.023↗
  4. Pancreatic cancer in patients with autoimmune pancreatitis: A scoping review. Co-author DOI 10.1016/j.pan.2021.03.007↗
  5. Is autoimmune pancreatitis a risk factor for pancreatic adenocarcinoma? First author DOI 10.36290/vnl.2021.011↗
  6. Helicobacter pylori infection and other bacteria in pancreatic cancer and autoimmune pancreatitis. First author DOI 10.4251/wjgo.v13.i8.835↗
  7. Pancreatic Solid Focal Lesions: Differential Diagnosis between Autoimmune Pancreatitis and Pancreatic Cancer. Co-author DOI 10.1159/000499762↗
  8. Immunoglobulin G4, autoimmune pancreatitis and pancreatic cancer. First author DOI 10.1159/000368337↗
  9. [Pain in chronic pancreatitis and pancreatic cancer - treatment options]. Last author PMID 24981695↗
  10. Differentiating autoimmune pancreatitis from pancreatic cancer. Co-author PMID 25288201↗
  11. Diabetes mellitus in pancreatic cancer patients in the Czech Republic: sex differences. First author DOI 10.1155/2012/414893↗
  12. The role of chronic inflammation: chronic pancreatitis as a risk factor of pancreatic cancer. Co-author DOI 10.1159/000336991↗
  13. [Pancreatic cancer--association with diabetes mellitus and smoking]. Co-author PMID 21416856↗
  14. Clinicopathological correlations of nestin expression in surgically resectable pancreatic cancer including an analysis of perineural invasion. Co-author PMID 22187705↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bohuslav Kianička · 7 shared papers, 2011–2024 · strength 0.85
  2. Martina Bojková · 6 shared papers, 2014–2024 · strength 0.79
  3. Arnošt Martínek · 5 shared papers, 2014–2024 · strength 0.54
  4. David Solil · 2 shared papers, 2024 · strength 0.52
  5. Michal Eid · 2 shared papers, 2021–2024 · strength 0.40
  6. Jiří Dolina · 2 shared papers, 2021–2024 · strength 0.36
  7. Lumír Kunovský · 3 shared papers, 2019–2021 · strength 0.34
  8. Jan Trna · 4 shared papers, 2011–2021 · strength 0.22
  9. Zdeněk Kala · 2 shared papers, 2011–2021 · strength 0.15
  10. Markéta Hermanová · 4 shared papers, 2011–2012 · strength 0.13
  11. Kensuke Kubota · 1 shared paper, 2021 · strength 0.11
  12. Itaru Naitoh · 1 shared paper, 2021 · strength 0.11
  13. Tsukasa Ikeura · 1 shared paper, 2021 · strength 0.11
  14. Terumi Kamisawa · 1 shared paper, 2021 · strength 0.11
  15. Tomáš Hucl · 1 shared paper, 2021 · strength 0.11
  16. Miroslav Vujasinović · 1 shared paper, 2021 · strength 0.11
  17. Peter Mačinga · 1 shared paper, 2021 · strength 0.11
  18. Marco Del Chiaro · 1 shared paper, 2021 · strength 0.11
  19. Suresh T. Chari · 1 shared paper, 2021 · strength 0.11
  20. Matthias J. Löhr · 1 shared paper, 2021 · strength 0.11
  21. Raffaele Pezzilli · 1 shared paper, 2021 · strength 0.11
  22. Kazuichi Okazaki · 1 shared paper, 2021 · strength 0.11
  23. Alice Bártková · 1 shared paper, 2012 · strength 0.03
  24. Renata Veselská · 1 shared paper, 2011 · strength 0.03
  25. Jiří Lenz · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.